Indefinite Delivery Contract SPE2DU25D5117

The Indefinite Delivery Contract (IDC) SPE2DU25D5117 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $999,999,999 and runs through December 2036, serving as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The IDC was derived from a pre-solicitation notice for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts, which DLA Troop Support plans to issue in March 2024. The solicitation aims to establish multiple regional contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and Naval Fleet. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made on a regional basis to at least three different contractors, with both primary and backup suppliers providing separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally.